Literature DB >> 6322299

Transformation and cytopathogenic effect in an immune human T-cell clone infected by HTLV-I.

H Mitsuya, H G Guo, M Megson, C Trainor, M S Reitz, S Broder.   

Abstract

Human T-cell leukemia-lymphoma virus (HTLV) is a human C-type retrovirus that can transform T lymphocytes in vitro and is associated with certain T-cell neoplasms. Recent data suggest that, in the United States, patients with acquired immunodeficiency syndrome (AIDS), homosexual men with lymphadenopathy, and hemophiliacs have had significant exposure rates to HTLV, whereas matched and unmatched control American subjects have rarely been exposed to this agent. In the present experiments, T cells specifically reactive against HTLV were propagated from a patient whose HTLV-bearing lymphoma was in remission. The T cells were cloned in the presence of the virus and an HTLV-specific cytotoxic T-cell clone was isolated. This clone was infected and transformed by the virus, with one copy of an HTLV-I provirus being integrated into the genome. This T-cell clone did not exhibit the normal dependence on T-cell growth factor (interleukin-2) and proliferated spontaneously in vitro. Exposure of the clone to HTLV-bearing, autologous tumor cells specifically inhibited its proliferation and resulted in its death. These results may have implications for HTLV-associated inhibition of T-cell responses.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6322299     DOI: 10.1126/science.6322299

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  10 in total

Review 1.  Viral modulation of T-cell receptor signaling.

Authors:  Keith R Jerome
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

2.  Deletional rearrangement in the human T-cell receptor alpha-chain locus.

Authors:  J P de Villartay; D Lewis; R Hockett; T A Waldmann; S J Korsmeyer; D I Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Pharmacological inhibition of in vitro infectivity of human T lymphotropic virus type I.

Authors:  S Matsushita; H Mitsuya; M S Reitz; S Broder
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

4.  Immunological functions and phenotypes of peripheral blood lymphocytes from human T-cell leukemia virus-I carriers.

Authors:  Y Tanaka; S Oda; K Nagata; N Mori; H Sakamoto; S Eto; U Yamashita
Journal:  J Clin Immunol       Date:  1989-11       Impact factor: 8.317

5.  Alterations in cytotoxic and helper T cell function after infection of T cell clones with human T cell leukemia virus, type I.

Authors:  R Yarchoan; H G Guo; M Reitz; A Maluish; H Mitsuya; S Broder
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

6.  Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1.

Authors:  L M Wahl; M L Corcoran; S W Pyle; L O Arthur; A Harel-Bellan; W L Farrar
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

7.  Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer.

Authors:  P W Kantoff; D B Kohn; H Mitsuya; D Armentano; M Sieberg; J A Zwiebel; M A Eglitis; J R McLachlin; D A Wiginton; J J Hutton
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

8.  Human T-cell leukemia virus type I infection of CD4+ or CD8+ cytotoxic T-cell clones results in immortalization with retention of antigen specificity.

Authors:  D V Faller; M A Crimmins; S J Mentzer
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

9.  Infection of human T lymphotropic virus-I-specific immune T cell clones by human T lymphotropic virus-I.

Authors:  H Mitsuya; R F Jarrett; J Cossman; O J Cohen; C S Kao; H G Guo; M S Reitz; S Broder
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

10.  Configuration and expression of the T cell receptor beta chain gene in human T-lymphotrophic virus I-infected cells.

Authors:  R F Jarrett; H Mitsuya; D L Mann; J Cossman; S Broder; M S Reitz
Journal:  J Exp Med       Date:  1986-02-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.